STRESS-INDUCED HYPERGLYCEMIA IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Abstract
The objective of the present research was to reveal the features of acute myocardial infarction in patients without violations of carbohydrate metabolism in the anamnesis complicated by the development of hyperglycemia and to create a mathematical model for assessment of the development of Diabetes Mellitus 2 types in the post-myocardial infarction period.
Results for examination of 185 patients with acute large-focal myocardial infarction (MI) without previous carbohydrate metabolism disorders are presented in the article. Patients with MI and hyperglycemia (HG) were characterized by more severe systemic inflammation, hemostasis disturbances and changes in the hormonal state than patients without HG. This was associated with more severe MI progression and more prominent changes in structural and functional cardiovascular parameters. The changes in patient outcomes and homeostasis parameters have been revealed depending on the dynamics of glycemia in the acute period of MI. We have developed a mathematical model for assessment of diabetes mellitus onset risks in patients with MI and HG.
About the Authors
E. S. Smirnova
Belarusian State Medical University, Minsk
Belarus
Belarus
Assistant
83, Dzerzhynskiy Ave., 220116
E. A. Grigorenko
Belarusian State Medical University, Minsk
Belarus
Belarus
Ph. D. (Med.), Assistant Professor
83, Dzerzhynskiy Ave., 220116
N. P. Mitkovskaya
Belarusian State Medical University, Minsk
Belarus
Belarus
D. Sc. (Med.), Professor, Head of the Department
83, Dzerzhynskiy Ave., 220116
References
1. Ibanez B., James S., Agewall S., Antunes M. J., Bucciarelli-Ducci C., Bueno H., Caforio A. L. P., Crea F., Goudevenos J. A., Halvorsen S., Hindricks G., Kastrati A., Lenzen M. J., Prescott E., Roffi M., Valgimigli M., Varenhorst C., Vranckx P., Widimský P. ESC guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 2017, ehx637. DOI: 10.1093/eurheartj/ehx637
2. Deedwania P., Kosiborod M., Barrett E., Ceriello A., Isley W., Mazzone T., Raskin P. hyperglycemia and acute coronary syndrome. A scientific statement from the american heart association diabetes committee of the council on nutrition, physical activity, and metabolism. Circulation, 2008, vol. 117, no. 12, pp. 1610–1619.
3. Mit’kovskaya N. P., Abel’skaya I. S., Postoyalko A. S., Statkevich T. V., Galitskaya S. S., Smirnova E. S., Balysh E. M., Samoliuk B. B. Predictors of adverse outcomes of percutaneous coronary interventions in patients with acute myocardial infarction with segment elevation ST. Meditsinskaya panorama [Medical Panorama], 2012, no. 4, pp. 3–5 (in Russian).
4. Savchenko A. P., Cherkavskaia O. V., Rudenko B. A., Bolotov P. A. Interventional cardiology. Coronary angiographyand stenting: practical guide. Moscow, GEOTAR-Media Publ., 2010. 448 p. (in Russian).
5. Shakhnovich R. M. Acute coronary syndrome with ST segment elevation: guide for doctors. Moscow, GEOTARMedia Publ., 2010. 376 p. (in Russian).
6. Stone G. W., Cox D., Garcia E., Brodie B. R., Morice M. C., Griffin J., Mattos L., Lansky A. J., O’Neill W. W., Grines C. L. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation, 2001, vol. 104, no. 6, pp. 636–641.
7. Antoni M. L., Hoogslag G. E., Boden H., Liem S. S., Boersma E., Fox K., Schalij M. J., Bax J. J., Delgado V. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (data from the leiden mission infarct registry). American Journal of Cardiology, 2012, vol. 109, no. 2, pp. 187–194.
8. Nechesova T. A., Korobko I. Yu., Kuznetsova N. I. Remodeling of the left ventricle: pathogenesis and evaluation methods. Meditsinskie novosti [Medical News], 2008, no. 11, pp. 7–13 (in Russian).
9. Khairutdinova G., Galiavich A. Diagnostic criteria for left ventricular remodeling in patients after a previous myocardial infarction with a merlon. Prakticheskaya meditsina [Practical Medicine], 2011, no. 4, pp. 75–79 (in Russian).
10. Antoni M. L., Hoogslag G. E., Boden H., Liem S. S., Boersma E., Fox K., Schalij M. J., Bax J. J., Delgado V. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (data from the leiden mission infarct registry). American Journal of Cardiology, 2012, vol. 109, no. 2, pp. 187–194. DOI: 10.1016/j.amjcard.2011.08.029
11. Oranskii P., Khanferian R. Cytokine levels in patients with Q-positive myocardial infarction in serum and cultures of blood mononuclear cells. Tsitokiny i vospalenie [Cytokines and Inflammation], 2009, vol. 8, no. 2, pp. 31–33 (in Russian). DOI: 10.1016/j.amjcard.2011.08.029
12. Solheim S., Grøgaard H. K., Hoffmann P., Arnesen H., Seljeflot I. Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris. Scandinavian Journal of Clinical and Laboratory Investigation, 2008, vol. 68, no. 7, pp. 555–562.
13. Ceriello A. Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings. Diabetes & Vascular Disease Research, 2008, vol. 5, no. 4, pp. 260–268. DOI: 10.3132/dvdr.2008.038
14. Zykov M. V., Barbarash O. L., Karetnikova V. N., Kashtalap V. V. The use of biomarkers-cytokines in the diagnosis and prediction of the course of myocardial infarction. Kemerevo, 2012. 24 p. (in Russian).
15. Lapshina L. A., Kravchun P. G., Titova A. Y., Glebova O. V. The value of the determination of nitrites-nitrates as markers of endothelial dysfunction in cardiovascular disease. Ukrai’ns’kyj medychnyj chasopys [Ukrainian Medical Journal], 2009, no. 6, pp. 49–53 (in Russian).
16. García R. G., Rincón M. Y., Arenas W. D., Silva S. Y., Reyes L. M., Ruiz S. L., Ramirez F., Camacho P. A., Luengas C., Saaibi J. F., Balestrini S., Morillo C., López-Jaramillo P. Hyperinsulinemia is a predictor of new cardiovascular events in Colombian patients with a first myocardial infarction. International Journal of Cardiology, 2011, vol. 148, no. 1, pp. 85–90. DOI: 10.1016/j.ijcard.2009.10.030
17. Panina A. V., Dovgalevskii Ya. P., Furman N. V., Puchinyan N. F., Bogomolova O. S. Prognostic value of elevated plasma D-dimer level in patients with acute coronary syndrome. Bulletin of Medical Internet Conferences, 2013, vol. 3, no. 6, p. 954 (in Russian).
18. Mit’kovskaya N. P., Statkevich T. V., Smirnova E. S., Balysh E. M., Galitskaya S. S., Cherviakova T. A., Troianova N. V., Kulazhenko I. O. Therapeutic tactics in patients with large-focal myocardial infarction and hyperglycaemia in terms of cardioprotection. Meditsinskaya panorama [Medical Panorama], 2012, no. 3, pp. 17–19 (in Russian).
19. Weir R. A., Tsorlalis I. K., Steedman T., Dargie H. J., Fraser R., McMurray J. J., Connell J. M. Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction. European Journal of Heart Fail, 2011, vol. 13, no. 12, pp. 1305–1313. DOI: 10.1093/eurjhf/hfr129
20. Duława A., Bułdak Ł., Krysiak R., Okopień B. Hormonal supplementation in endocrine dysfunction in critically ill patients. Pharmacological Reports, 2007, vol. 59, no. 2, pp. 139–149.
21. Wallander M., Soderberg S., Norhammar A. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes. Diabetic Medicine, 2008, vol. 25, no. 8, pp. 949– 955. DOI: 10.1111/j.1464–5491.2008.02509.x
22. Mit’kovskaya N. P., Grigorenko E. A., Danilova L. I. Heart and metabolic risk. Minsk, Belorusskaya nauka Publ., 2008. 277 p. (in Russian).
23. Pallan S. Effects and mechanisms of action of leptin on cardiomyocytes [Electronic resourse]. Journal of Young Investigators, 2004, no. 2. Available at: http://www.jyi.org/issue/effects-and-mechanisms-of-action-of-leptin-on-cardiomyocytes.html (accessed 05.05.2016).
24. Moiseev V. S., Mil’to A. S., Pavlikova E. P., Tolkacheva V. V. Prognostic value and the possibility of correction of hyperglycemia in patients with acute coronary syndrome. Klinicheskaya farmakologiia i terapiya [Clinical Pharmacology and Therapy], 2008, no. 2, pp. 65–73 (in Russian).
Review
For citations:
Smirnova E.S., Grigorenko E.A., Mitkovskaya N.P. STRESS-INDUCED HYPERGLYCEMIA IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2017;(4):60-69. (In Russ.)
Views: 806
Email this article 